Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
Here's What Key Metrics Tell Us About Abbott (ABT) Q2 Earnings
10:36am, Thursday, 16'th Jul 2026
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street est
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
10:11am, Thursday, 16'th Jul 2026
U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Thursday.
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
09:41am, Thursday, 16'th Jul 2026
Abbott (ABT) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.26 per share a year ago.
Abbott Laboratories Sales Rise on Diagnostics Growth
08:08am, Thursday, 16'th Jul 2026
The healthcare company said its profit fell to $928 million, or 53 cents a share, in the second quarter, from $1.78 billion, or $1.01 a share, a year earlier.
Nasdaq dragged by chip sell-off, Abbott, UnitedHealth lead risers
07:53am, Thursday, 16'th Jul 2026
11:50am: AI stocks out of favor Investors are still favoring stocks with little direct exposure to AI, according to Chris Beauchamp, Chief Market Analyst at...
What Investors Don't Understand About Abbott Laboratories
07:40am, Thursday, 16'th Jul 2026
The market still treats Abbott Laboratories (NYSE:ABT | ABT Price Prediction) like a bond proxy with a stethoscope: baby formula, branded generics, and a metronomic dividend.
Abbott raises 2026 profit forecast on heart device strength
07:33am, Thursday, 16'th Jul 2026
Abbott raised its annual profit forecast on Thursday, as it expects strong demand for its heart devices in the second half of the year.
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
07:30am, Thursday, 16'th Jul 2026
Second-quarter reported sales growth of 13.0 percent; comparable sales growth of 4.8 percent Second-quarter GAAP diluted EPS of $0.53; adjusted diluted EPS of $1.31 Abbott reaffirms full-year 2026 com
Ora Banda delivers record gold quarter as ‘DRIVE to 300’ expansion gathers momentum
05:16am, Thursday, 16'th Jul 2026
Ora Banda Mining Ltd (ASX:OBM, OTC:ESGFF) has closed FY2026 with record quarterly gold production, strong cash flow and a larger resource base. The company...
UnitedHealth, Abbott Laboratories And 3 Stocks To Watch Heading Into Thursday
03:18am, Thursday, 16'th Jul 2026
With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Reasons to Retain Abbott Stock in Your Portfolio for Now
01:05pm, Wednesday, 15'th Jul 2026
ABT is banking on emerging-market pharmaceutical growth and innovation in Nutrition, but macro pressures and currency swings remain key challenges.
Nasdaq closes higher as Apple, soft PPI lift stocks
12:19pm, Wednesday, 15'th Jul 2026
4:15pm: Apple surges, inflation cools Stocks finished higher on Wednesday as another softer-than-expected inflation report reinforced expectations that the...
Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?
10:35am, Tuesday, 14'th Jul 2026
ABT heads into Q2 earnings results with growth expected across Diagnostics, Devices and EPD, while Nutrition remains a drag. Here's what could shape the results.
Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?
04:47pm, Monday, 13'th Jul 2026
Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Pfizer (NYSE: PFE) both delivered Q1 2026 beats, yet the market treats them differently.
Unlocking Q2 Potential of Abbott (ABT): Exploring Wall Street Estimates for Key Metrics
10:15am, Monday, 13'th Jul 2026
Beyond analysts' top-and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter en
